V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220005194 | 220002033 | 0 | 78 | Not known (9) | 2014-06-21 | 2014-06-21 | AML17 TRIAL | 1 | N | 220027648 | AML17 TRIAL |
| 220005196 | 220002034 | 1.61 | null | Disease modification (D) | 2014-12-25 | 2014-12-28 | Cytarabine low (10to20mg/m2) IV/SC | 2 | N | 220027658 | CYTARABINE |
| 220005197 | 220011081 | 1.62 | null | Palliative (P) | 2014-08-19 | 2014-08-20 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220027659 | CYTARABINE |
| 220005198 | 220002035 | null | 84.5 | Palliative (P) | 2014-12-01 | 2014-12-01 | CYTARABINE | N | N | 220027661 | CYTARABINE |
| 220005199 | 220002035 | 1.69 | null | Curative (C) | 2013-06-08 | 2013-06-13 | CYTARABINE | N | N | 220027661 | CYTARABINE |
| 220005200 | 220002036 | 1.88 | null | Disease modification (D) | null | 2015-02-03 | Cytarabine Low Dose | N | N | 220027663 | CYTARABINE |
| 220005201 | 220002037 | 0 | 95.2 | Curative (C) | 2015-08-11 | 2015-08-11 | Trial Unspecified | Y | N | 220027665 | TRIAL |
| 220005202 | 220002037 | null | null | Curative (C) | 2014-08-06 | 2014-08-06 | AML17 TRIAL | N | Y | 220027665 | AML17 TRIAL |
| 220005203 | 220002038 | 1.88 | 80 | Curative (C) | 2017-05-16 | 2017-05-16 | AML17 TRIAL | N | N | 220027667 | AML17 TRIAL |
| 220005204 | 220011084 | null | 77.3 | Curative (C) | 2014-08-17 | 2014-08-17 | Trial Unspecified | 1 | N | 220027669 | TRIAL |
| 220005208 | 220002040 | 1.73 | 61.4 | Curative (C) | null | 2014-03-21 | Trial Unspecified | N | null | 220027684 | TRIAL |
| 220005209 | 220002040 | 1.65 | null | Curative (C) | 2014-06-26 | 2014-06-26 | Trial Unspecified | Y | null | 220027684 | TRIAL |
| 220005210 | 220002041 | null | 108.4 | Curative (C) | 2017-06-20 | 2017-06-25 | Trial Unspecified | N | N | 220027687 | TRIAL |
| 220005211 | 220002041 | null | 67.5 | Palliative (P) | 2013-11-10 | 2013-11-10 | Cytarabine Low Dose | N | N | 220027687 | CYTARABINE |
| 220005212 | 220002041 | 1.7 | 76 | Adjuvant (A) | 2014-11-03 | 2014-11-03 | Trial Unspecified | Y | N | 220027687 | TRIAL |
| 220005213 | 220002041 | null | 100 | Curative (C) | 2014-04-30 | 2014-04-30 | Trial Unspecified | 01 | N | 220027687 | TRIAL |
| 220005214 | 220002042 | null | null | Palliative (P) | 2016-06-06 | 2016-06-06 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220027692 | CYTARABINE |
| 220005215 | 220002043 | null | null | Disease modification (D) | 2017-06-07 | 2017-06-07 | CYTARABINE | N | null | 220027702 | CYTARABINE |
| 220005216 | 220011088 | 1.69 | 92 | Curative (C) | 2015-12-28 | 2016-01-04 | Trial Unspecified | Y | N | 220027703 | TRIAL |
| 220005217 | 220011088 | null | 82 | Curative (C) | 2013-10-05 | 2013-10-05 | LI-1 TRIAL | 1 | null | 220027703 | TRIAL |
| 220005218 | 220002044 | 1.72 | 121 | Curative (C) | 2015-09-19 | 2015-10-01 | Trial Unspecified | Y | N | 220027707 | TRIAL |
| 220005219 | 220002044 | 1.76 | null | Disease modification (D) | 2017-02-26 | 2017-03-08 | Cytarabine Low Dose | 2 | N | 220027707 | CYTARABINE |
| 220005220 | 220002045 | null | 65.8 | Not known (9) | 2015-12-26 | 2015-12-26 | AML17 TRIAL | 01 | null | 220027710 | AML17 TRIAL |
| 220005221 | 220002045 | 1.85 | null | Disease modification (D) | 2017-07-02 | 2017-07-04 | Trial Unspecified | 1 | null | 220027710 | TRIAL |
| 220005224 | 220002047 | 0 | 0 | Palliative (P) | 2013-01-19 | 2013-01-20 | CYTARABINE | null | null | 220027721 | CYTARABINE |
| 220005225 | 220002047 | null | 82.9 | Curative (C) | 2017-06-23 | 2017-06-24 | AML17 TRIAL | Y | null | 220027721 | AML17 TRIAL |
| 220005226 | 220002048 | 1.66 | 73.8 | Curative (C) | 2015-03-31 | 2015-03-31 | AML17 TRIAL | 02 | N | 220027724 | AML17 TRIAL |
| 220005227 | 220002048 | 0 | 65.8 | Curative (C) | 2013-09-30 | 2013-10-03 | AML17 TRIAL | 01 | N | 220027724 | AML17 TRIAL |
| 220005228 | 220002048 | 1.55 | 50.1 | Curative (C) | null | 2015-02-25 | AML17 TRIAL | Y | null | 220027724 | AML17 TRIAL |
| 220005230 | 220002050 | 1.62 | 55 | Curative (C) | 2017-09-18 | 2017-09-19 | AML17 TRIAL | Y | N | 220027730 | AML17 TRIAL |
| 220005231 | 220011094 | 1.75 | 95.5 | Palliative (P) | 2016-05-25 | 2016-06-03 | Trial Unspecified | 1 | N | 220027733 | TRIAL |
| 220005232 | 220011094 | 1.86 | 77.2 | null | 2013-11-02 | 2013-11-02 | AML17 TRIAL | Y | N | 220027733 | AML17 TRIAL |
| 220005233 | 220018732 | 1.73 | null | Curative (C) | 2013-03-02 | 2013-03-02 | Trial Unspecified | 01 | N | 220027737 | TRIAL |
| 220005234 | 220018732 | 1.72 | 73 | null | 2016-02-01 | 2016-02-01 | Trial Unspecified | 01 | null | 220027737 | TRIAL |
| 220005235 | 220002051 | 1.63 | null | Curative (C) | null | 2016-01-22 | AML17 TRIAL | null | null | 220027741 | AML17 TRIAL |
| 220005236 | 220002052 | 1.73 | 86 | Curative (C) | 2016-01-08 | 2016-01-12 | AML17 TRIAL | 1 | N | 220027742 | AML17 TRIAL |
| 220005237 | 220011095 | null | 0 | Palliative (P) | 2014-08-15 | 2014-08-17 | Cytarabine Low Dose | 02 | null | 220027747 | CYTARABINE |
| 220005238 | 220011095 | 1.75 | 58 | Curative (C) | 2013-12-01 | 2013-12-01 | CYTARABINE | N | N | 220027747 | CYTARABINE |
| 220005239 | 220002053 | null | 63 | Palliative (P) | 2016-07-12 | 2016-07-12 | Cytarabine Low Dose | 02 | null | 220027749 | CYTARABINE |
| 220005240 | 220002053 | null | 46.8 | Curative (C) | 2015-10-11 | 2015-10-12 | Cytarabine Low Dose | N | N | 220027749 | CYTARABINE |
| 220005241 | 220002053 | 1.6 | 56.2 | Curative (C) | null | 2017-05-10 | AML17 TRIAL | null | null | 220027749 | AML17 TRIAL |
| 220005242 | 220002054 | 1.73 | null | Disease modification (D) | 2014-05-26 | 2014-05-26 | Trial Unspecified | 1 | N | 220027754 | TRIAL |
| 220005243 | 220002055 | 1.5 | 68 | null | 2016-03-22 | 2016-03-25 | AML17 TRIAL | Y | N | 220027755 | AML17 TRIAL |
| 220005244 | 220002056 | null | null | Not known (9) | 2017-12-15 | 2017-12-18 | AML17 TRIAL | 01 | N | 220027756 | AML17 TRIAL |
| 220005245 | 220002056 | null | 97 | Palliative (P) | 2013-04-09 | 2013-04-13 | Cytarabine Low Dose | N | N | 220027756 | CYTARABINE |
| 220005246 | 220002056 | 1.86 | 73.4 | Curative (C) | 2014-07-08 | 2014-07-21 | Trial Unspecified | Y | N | 220027756 | TRIAL |
| 220005247 | 220002057 | 1.69 | 78.8 | Curative (C) | 2014-07-24 | 2014-07-24 | AML17 TRIAL | Y | N | 220027763 | AML17 TRIAL |
| 220005248 | 220002057 | null | 100.9 | Curative (C) | 2014-10-14 | 2014-10-16 | Trial Unspecified | 1 | null | 220027763 | TRIAL |
| 220005249 | 220002058 | 1.78 | 83.6 | Curative (C) | 2017-03-09 | 2017-03-09 | AML17 TRIAL | N | N | 220027770 | AML17 TRIAL |
| 220005250 | 220002058 | 1.63 | 77.5 | Disease modification (D) | 2013-06-22 | 2013-06-22 | Cytarabine Low Dose | N | N | 220027770 | CYTARABINE |